DRI HEALTHCARE TRUST (DHT-UN.CA) Fundamental Analysis & Valuation

TSX:DHT-UN • CA23344H1091

Current stock price

16.79 CAD
-0.21 (-1.24%)
Last:

This DHT-UN.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. DHT-UN.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DHT-UN was profitable.
  • DHT-UN had a positive operating cash flow in the past year.
  • In multiple years DHT-UN reported negative net income over the last 5 years.
  • In the past 5 years DHT-UN always reported a positive cash flow from operatings.
DHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFDHT-UN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • DHT-UN's Return On Assets of -5.75% is in line compared to the rest of the industry. DHT-UN outperforms 55.88% of its industry peers.
  • With a decent Return On Equity value of -11.95%, DHT-UN is doing good in the industry, outperforming 61.76% of the companies in the same industry.
  • DHT-UN has a Return On Invested Capital of 4.55%. This is in the better half of the industry: DHT-UN outperforms 76.47% of its industry peers.
  • DHT-UN had an Average Return On Invested Capital over the past 3 years of 1.94%. This is significantly below the industry average of 8.22%.
  • The 3 year average ROIC (1.94%) for DHT-UN is below the current ROIC(4.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -5.75%
ROE -11.95%
ROIC 4.55%
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
DHT-UN.CA Yearly ROA, ROE, ROICDHT-UN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 -5 10 -10 15

1.3 Margins

  • DHT-UN has a better Operating Margin (27.25%) than 94.12% of its industry peers.
  • In the last couple of years the Operating Margin of DHT-UN has declined.
  • The Profit Margin and Gross Margin are not available for DHT-UN so they could not be analyzed.
Industry RankSector Rank
OM 27.25%
PM (TTM) N/A
GM N/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHT-UN.CA Yearly Profit, Operating, Gross MarginsDHT-UN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHT-UN.CA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DHT-UN is destroying value.
  • Compared to 1 year ago, DHT-UN has less shares outstanding
  • The debt/assets ratio for DHT-UN is higher compared to a year ago.
DHT-UN.CA Yearly Shares OutstandingDHT-UN.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
DHT-UN.CA Yearly Total Debt VS Total AssetsDHT-UN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.45, we must say that DHT-UN is in the distress zone and has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.45, DHT-UN is doing good in the industry, outperforming 76.47% of the companies in the same industry.
  • DHT-UN has a debt to FCF ratio of 4.45. This is a neutral value as DHT-UN would need 4.45 years to pay back of all of its debts.
  • DHT-UN's Debt to FCF ratio of 4.45 is fine compared to the rest of the industry. DHT-UN outperforms 76.47% of its industry peers.
  • DHT-UN has a Debt/Equity ratio of 0.90. This is a neutral value indicating DHT-UN is somewhat dependend on debt financing.
  • DHT-UN's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. DHT-UN is outperformed by 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.45
Altman-Z 1.45
ROIC/WACC0.55
WACC8.28%
DHT-UN.CA Yearly LT Debt VS Equity VS FCFDHT-UN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • DHT-UN has a Current Ratio of 1.14. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
  • DHT-UN has a Current ratio of 1.14. This is in the lower half of the industry: DHT-UN underperforms 76.47% of its industry peers.
  • DHT-UN has a Quick Ratio of 1.14. This is a normal value and indicates that DHT-UN is financially healthy and should not expect problems in meeting its short term obligations.
  • DHT-UN's Quick ratio of 1.14 is in line compared to the rest of the industry. DHT-UN outperforms 52.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.14
DHT-UN.CA Yearly Current Assets VS Current LiabilitesDHT-UN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. DHT-UN.CA Growth Analysis

3.1 Past

  • The earnings per share for DHT-UN have decreased by -7.41% in the last year.
  • DHT-UN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.09% yearly.
  • DHT-UN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.24%.
  • DHT-UN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.25% yearly.
EPS 1Y (TTM)-7.41%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%7%

3.2 Future

  • DHT-UN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.76% yearly.
  • DHT-UN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.38% yearly.
EPS Next Y-4.49%
EPS Next 2Y2.71%
EPS Next 3Y7.24%
EPS Next 5Y16.76%
Revenue Next Year12.6%
Revenue Next 2Y6.43%
Revenue Next 3Y6.15%
Revenue Next 5Y14.38%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DHT-UN.CA Yearly Revenue VS EstimatesDHT-UN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
DHT-UN.CA Yearly EPS VS EstimatesDHT-UN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. DHT-UN.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • DHT-UN is valuated cheaply with a Price/Earnings ratio of 7.46.
  • DHT-UN's Price/Earnings ratio is rather cheap when compared to the industry. DHT-UN is cheaper than 88.24% of the companies in the same industry.
  • DHT-UN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.70.
  • DHT-UN is valuated cheaply with a Price/Forward Earnings ratio of 7.33.
  • 82.35% of the companies in the same industry are more expensive than DHT-UN, based on the Price/Forward Earnings ratio.
  • DHT-UN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 7.46
Fwd PE 7.33
DHT-UN.CA Price Earnings VS Forward Price EarningsDHT-UN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DHT-UN is valued a bit cheaper than 67.65% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DHT-UN is valued a bit cheaper than 76.47% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.12
EV/EBITDA 8.74
DHT-UN.CA Per share dataDHT-UN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.71%
EPS Next 3Y7.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DHT-UN.CA Dividend Analysis

5.1 Amount

  • DHT-UN has a Yearly Dividend Yield of 4.57%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.37, DHT-UN pays a better dividend. On top of this DHT-UN pays more dividend than 97.06% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, DHT-UN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.57%

5.2 History

  • DHT-UN has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DHT-UN.CA Yearly Dividends per shareDHT-UN.CA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DPN/A
EPS Next 2Y2.71%
EPS Next 3Y7.24%
DHT-UN.CA Yearly Income VS Free CF VS DividendDHT-UN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 0 50M -50M 100M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHT-UN.CA Fundamentals: All Metrics, Ratios and Statistics

DRI HEALTHCARE TRUST

TSX:DHT-UN (3/13/2026, 7:00:00 PM)

16.79

-0.21 (-1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners51.66%
Inst Owner ChangeN/A
Ins Owners0.97%
Ins Owner ChangeN/A
Market Cap923.62M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Analysts80
Price Target22.04 (31.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.57%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.74%
Min EPS beat(2)-4.46%
Max EPS beat(2)0.99%
EPS beat(4)2
Avg EPS beat(4)3.59%
Min EPS beat(4)-21.52%
Max EPS beat(4)39.35%
EPS beat(8)5
Avg EPS beat(8)18.58%
EPS beat(12)6
Avg EPS beat(12)10.35%
EPS beat(16)8
Avg EPS beat(16)65.99%
Revenue beat(2)1
Avg Revenue beat(2)3.28%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)6.93%
Revenue beat(4)2
Avg Revenue beat(4)13.03%
Min Revenue beat(4)-0.64%
Max Revenue beat(4)46.19%
Revenue beat(8)5
Avg Revenue beat(8)25.66%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.19%
EPS NQ rev (1m)1.01%
EPS NQ rev (3m)0.75%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.78%
Revenue NY rev (1m)1.11%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 7.46
Fwd PE 7.33
P/S 4.79
P/FCF 9.12
P/OCF 9.03
P/B 2.11
P/tB N/A
EV/EBITDA 8.74
EPS(TTM)2.25
EY13.4%
EPS(NY)2.29
Fwd EY13.64%
FCF(TTM)1.84
FCFY10.96%
OCF(TTM)1.86
OCFY11.07%
SpS3.5
BVpS7.95
TBVpS-5.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.06
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -11.95%
ROCE 6.33%
ROIC 4.55%
ROICexc 4.76%
ROICexgc 98.84%
OM 27.25%
PM (TTM) N/A
GM N/A
FCFM 52.55%
ROA(3y)4.16%
ROA(5y)N/A
ROE(3y)6.27%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)2.05%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.74%
ROCE(5y)N/A
ROICexgc growth 3Y44.9%
ROICexgc growth 5YN/A
ROICexc growth 3Y-7.25%
ROICexc growth 5YN/A
OM growth 3Y-6.12%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 4.45
Debt/EBITDA 2.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 66.17%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.14
Altman-Z 1.45
F-Score4
WACC8.28%
ROIC/WACC0.55
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3Y5.09%
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-4.49%
EPS Next 2Y2.71%
EPS Next 3Y7.24%
EPS Next 5Y16.76%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y32.25%
Revenue growth 5YN/A
Sales Q2Q%7%
Revenue Next Year12.6%
Revenue Next 2Y6.43%
Revenue Next 3Y6.15%
Revenue Next 5Y14.38%
EBIT growth 1Y343.32%
EBIT growth 3Y24.15%
EBIT growth 5YN/A
EBIT Next Year108.89%
EBIT Next 3Y29%
EBIT Next 5Y27.95%
FCF growth 1Y103.46%
FCF growth 3Y19.16%
FCF growth 5YN/A
OCF growth 1Y103.46%
OCF growth 3Y19.16%
OCF growth 5YN/A

DRI HEALTHCARE TRUST / DHT-UN.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to DHT-UN.CA.


What is the valuation status of DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

ChartMill assigns a valuation rating of 6 / 10 to DRI HEALTHCARE TRUST (DHT-UN.CA). This can be considered as Fairly Valued.


How profitable is DRI HEALTHCARE TRUST (DHT-UN.CA) stock?

DRI HEALTHCARE TRUST (DHT-UN.CA) has a profitability rating of 3 / 10.


What is the valuation of DRI HEALTHCARE TRUST based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DRI HEALTHCARE TRUST (DHT-UN.CA) is 7.46 and the Price/Book (PB) ratio is 2.11.